Safety and Efficacy of Once-Daily Prolonged-Release Tacrolimus in Living Donor Liver Transplantation: An Open-Label, Prospective, Single-Arm, Phase 4 Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety and Efficacy of Once-Daily Prolonged-Release Tacrolimus in Living Donor Liver Transplantation: An Open-Label, Prospective, Single-Arm, Phase 4 Study

Published:2018-10-12 Issue: Volume:23 Page:713-720
ISSN:2329-0358
Container-title:Annals of Transplantation
language:en
Short-container-title:Ann Transplant

Author:

Lee Eung Chang¹,Kim Seong Hoon¹,Park Sang-Jae¹

Affiliation:

1. Center for Liver Cancer, National Cancer Center, Goyang, Gyeonggi, South Korea

Publisher

International Scientific Information, Inc.

Subject

Transplantation,General Medicine

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lebendspende Lebertransplantation für erwachsene Empfänger;Organtransplantation mit Lebendspende;2023

2. Impact of single-nucleotide polymorphisms on tacrolimus pharmacokinetics in liver transplant patients after switching to once-daily dosing;Hepatology International;2022-08-16

3. Medication Non-adherence among Liver Transplant Recipients;Current Hepatology Reports;2020-10-24

4. Novel regulators of PrPC expression as potential therapeutic targets in prion diseases;Expert Opinion on Therapeutic Targets;2020-07-07

5. Hydrogen‐rich water alleviates cyclosporine A‐induced nephrotoxicity via the Keap1/Nrf2 signaling pathway;Journal of Biochemical and Molecular Toxicology;2020-02-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP